This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Cardiomyocyte NLRP3 signaling in right heart failure is sexually dimorphic via estrogen receptor α.
bioRxiv : the preprint server for biology · 2026
IGFBP7 Contributes to Endothelial-to-Mesenchymal Transition and Serves as a Biomarker for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
American journal of respiratory cell and molecular biology · 2026
Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges.
Journal of translational medicine · 2025
Latest funding
- $856,800
Targeting Integrin Signaling to Alleviate Remodeling in Pulmonary Arteries and the Right Ventricle in Pulmonary Hypertension
CIHR · 2024 · Nominated PI
- $864,450
Targeting Mitosis and Senescence to Reverse Pulmonary Hypertension: A Promising Therapeutic Strategy
CIHR · 2023 · Co-investigator
- $742,050
ATP Citrate Lyase: an attractive target at the nexus of metabolic and epigenetic alterations in pulmonary arterial hypertension
CIHR · 2021 · Nominated PI
73 publications.
Cardiomyocyte NLRP3 signaling in right heart failure is sexually dimorphic via estrogen receptor α.
Fais RS, das Neves Palotta E, Kopf KW, Massad KM, Neto-Neves EM, Hoffer C, Walts AD, Frump AL, Goldenberg NM, Givens S, Bourgeois A, Woodcock CC, Petrache I, Chesler NC, Woulfe KC, Pullamsetti SS, Boucherat O, Provencher S, Ogle BM, Bonnet S, Lahm T
IGFBP7 Contributes to Endothelial-to-Mesenchymal Transition and Serves as a Biomarker for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Deng L, Wang Z, Boucherat O, Leng B, Cao C, He M, Cai Z, Chen Z, Wu G, Bonnet S, Wei W, Bian JS
Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges.
Niu Y, Tian J, Provencher S, Bonnet S, Boucherat O, Potus F, Gou D
Cellular senescence in adult pulmonary hypertension: current state and future challenges.
Lemay SE, Kuwabara Y, Bonnet S, Potus F, Provencher S, Adnot S, Boucherat O
Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension.
Kuwabara Y, Yokokawa T, Lemay SE, Sauvaget M, Martineau S, Breuils-Bonnet S, Potus F, Bonnet S, Provencher S, Boucherat O
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.
Lemay SE, Montesinos MS, Grobs Y, Yokokawa T, Shimauchi T, Mougin M, Romanet C, Sauvaget M, Breuils-Bonnet S, Bourgeois A, Théberge C, Pelletier A, El Kabbout R, Martineau S, Yamamoto K, Akram M, Ray AS, Lippa B, Goodwin B, Lin FY, Wang H, Dowling JE, Lu M, Qiao Q, McTeague TA, Moy TI, Potus F, Provencher S, Boucherat O, Bonnet S
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies.
Lemay SE, Mougin M, Sauvaget M, El Kabbout R, Valasarajan C, Yamamoto K, Martineau S, Pelletier A, Bilodeau C, Grobs Y, Bourgeois A, Romanet C, Breuils-Bonnet S, Montesinos MS, Lu M, Chen H, Gilbert M, Théberge C, Potus F, Pullamsetti S, Provencher S, Bonnet S, Boucherat O
Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension.
Pi H, Xia L, Boucherat O, Suresh K, Hemnes AR, Bonnet S, Bravo CA, Oppegard L, Rayner SG, Shojaie A, Gharib SA, Leary PJ
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
Tang H, Gupta A, Morrisroe SA, Bao C, Schwantes-An TH, Gupta G, Liang S, Sun Y, Chu A, Luo A, Ramamoorthi Elangovan V, Sangam S, Shi Y, Naidu SR, Jheng JR, Ciftci-Yilmaz S, Warfel NA, Hecker L, Mitra S, Coleman AW, Lutz KA, Pauciulo MW, Lai YC, Javaheri A, Dharmakumar R, Wu WH, Flaherty DP, Karnes JH, Breuils-Bonnet S, Boucherat O, Bonnet S, Yuan JX, Jacobson JR, Duarte JD, Nichols WC, Garcia JGN, Desai AA
Seeing pulmonary hypertension through a paediatric lens: a viewpoint.
Agarwal S, Fineman J, Cornfield DN, Alvira CM, Zamanian RT, Goss K, Yuan K, Bonnet S, Boucherat O, Pullamsetti S, Alcázar MA, Goncharova E, Kudryashova TV, Nicolls MR, de Jesús Pérez V
Targeting Integrin Signaling to Alleviate Remodeling in Pulmonary Arteries and the Right Ventricle in Pulmonary Hypertension
Principal investigators: Boucherat, Olivier
Keywords: Pulmonary Hypertension; Pulmonary Vascular Disease
Targeting Mitosis and Senescence to Reverse Pulmonary Hypertension: A Promising Therapeutic Strategy
Principal investigators: Provencher, Steeve
Keywords: Pulmonary Hypertension, Lung Disease
ATP Citrate Lyase: an attractive target at the nexus of metabolic and epigenetic alterations in pulmonary arterial hypertension
Principal investigators: Boucherat, Olivier
Keywords: Pulmonary Hypertension; Pulmonary Vascular Disease
The anti-oxidative DNA damage protein MTH1, the novel pulmonary hypertension Achilles heel.
Principal investigators: Bonnet, Sébastien
Keywords: Oxidative Damage; Pulmonary Hypertension
Role of the long non-coding RNA H19 as a novel biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension
Principal investigators: Boucherat, Olivier
Keywords: Heart Failure; Long Non-Coding Rna; Pulmonary Hypertension; Right Ventricular Dysfunction
Replication stress and pulmonary hypertension: Role for checkpoint kinase 1
Principal investigators: Bonnet, Sébastien
Keywords: Dna Damage; Mirnas; Pulmonary Hypertension; Vascular Remodeling
Prohibitin: a circulating mitokine involved in the Pulmonary Arterial Hypertension Syndrome.
Principal investigators: Paulin, Roxane V
Keywords: Circulating Factor; Metabolism; Mitokines; Prohibitins; Pulmonary Hypertension
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Médecine
- Medicine
- Department of Medicine
- Physical Therapy
- Cardiology
- Other
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Steeve Provencher
Médecine
40 shared papers, latest 2025
Roxane Paulin
Medicine
22 shared papers, latest 2022
Sébastien Bonnet
Médecine
14 shared papers, latest 2026
Lucie Jeannotte
Faculty
12 shared papers, latest 2018
Francois Potus
Faculty
4 shared papers, latest 2023
Jean Charron
Faculty
3 shared papers, latest 2017
Mathieu Morissette
Médecine
1 shared papers, latest 2018
Benjamin Hibbert
Department of Medicine
1 shared papers, latest 2018
Philippe Joubert
Faculty
1 shared papers, latest 2018
Jason Weatherald
Physical Therapy
1 shared papers, latest 2022
Jason Weatherald
Medicine
1 shared papers, latest 2022
Jamila Chakir
Médecine
1 shared papers, latest 2012
Philippe Pibarot
Cardiology
1 shared papers, latest 2019
Gopinath Sutendra
Medicine
1 shared papers, latest 2018
Mathieu Laplante
Medicine
1 shared papers, latest 2018
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.